← Back to Search

Antibiotic

Vancomycin for Osteomyelitis

Phase 3

Waitlist Available

Led By Christian Ramers, MD

Research Sponsored by University of Washington

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial compares the effectiveness of two drugs to treat a type of bone infection caused by MRSA.

Eligible Conditions

Osteomyelitis
MRSA

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Clinical cure

Trial Design

2Treatment groups

Active Control

Group I: VancomycinActive Control1 Intervention

Vancomycin, dosage to be determined by serum levels, medication provided by vein and duration 6-12 weeks

Group II: Trimethoprim-sulfamethoxazoleActive Control2 Interventions

trimethoprim-sulfamethoxazole, double strength, 2-3 tabs twice a day by mouth for 6-12 weeks

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor

1,744 Previous Clinical Trials

1,848,344 Total Patients Enrolled

2 Trials studying Osteomyelitis

418 Patients Enrolled for Osteomyelitis

Christian Ramers, MDPrincipal InvestigatorUniversity of Washington

1 Previous Clinical Trials

20 Total Patients Enrolled

Jeanne M Marrazzo, MD, MPHPrincipal InvestigatorUW

1 Previous Clinical Trials

120 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any past investigations involving the compound 2?

"Presently, 69 active clinical trials for 2 are underway with 10 of those studies being in the last phase. The majority of these tests are located in Jupiter, Florida while 394 different centres participate."

Answered by AI

What health issues is 2 regularly used to treat?

"genus pneumocystis is often treated with 2, though it has also been known to be useful in treating enteritis infections caused by shigella flexneri and sonnei as well as otitis media."

Answered by AI

What is the quota for participants in this trial?

"Unfortunately, this clinical trial is not accepting participants at the moment. It was first posted on May 1st 2006 and last updated in July 2009. If you are interested in other trials related to osteomyelitis, there are 32 studies actively recruiting patients while 69 have slots open for two more volunteers."

Answered by AI

Are there any available vacancies in this clinical experiment?

"This clinical research is not currently enrolling patients. Initially posted on May 1st 2006 with the latest update being July 27th 2009, participants are encouraged to seek other studies as there are 32 medical trials for osteomyelitis and 69 for two different interventions actively recruiting."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis

Robert Harrington 2006. "Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00324922.